Sort
38,696 grants matching “als”
Mechanisms of Symptoms of Multiple Myeloma and Its Therapy
$2,183,628Charles S Cleeland · University Of Tx Md Anderson Can Ctr · P01 · FY2010 · CA
Cellular and Molecular Pathways for Hearing Restoration in the Adult Inner Ear
$2,182,436Michael Hoa · National Institute On Deafness And Other Communication Disorders · ZIA · FY2022 · DC
Biochemical and Biological Properties of Actins and Myosins
$2,180,488Edward D Korn · Heart, Lung, And Blood Institute · Z01 · FY2007 · HL
Integrative analysis and modeling of human immune responses and pathologies
$2,180,475John Tsang · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Thailand HIV/AIDS and Infectious Disease Clinical Trials Unit (THAI CTU)
$2,180,389Suwat Chariyalertsak · Chiang Mai University · UM1 · FY2019 · AI
A PHASE 1C STUDY OF PROSETIN, A NOVEL, BRAIN-PENETRANT MAP4K INHIBITOR, IN PARTICIPANTS WITH ALS
$2,180,261Projenx Inc · · FY2025 · Defense Health Agency
Molecular signaling during development and maturation of the nervous system
$2,179,383David Talmage · National Institute Of Neurological Disorders And Stroke · ZIA · FY2022 · NS
PHYSIOLOGICAL CONSEQUENCES OF PULMONARY DISEASE
$2,175,304University Of California San Diego · P01 · FY2003 · HL
Role of long non-coding RNAs and RNA-binding proteins in p53 signaling
$2,172,597Ashish Lal · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Glial regulation of ER stress resistance
$2,169,819Ashley Frakes · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK
Drug Repurposing Screening for Rare and Neglected Diseases
$2,167,870Wei Zheng · National Center For Advancing Translational Sciences · ZIA · FY2018 · TR
Pro-inflammatory cytokine lowering anti-inflammatory drugs
$2,166,049Nigel H. Greig · National Institute On Aging · ZIA · FY2023 · AG
Research and Education Cyberinfrastructure Investments to Develop the Coastal Hazards Collaboratory in the Northern Gulf Coast
$2,166,000Michael M Khonsari · Louisiana Board Of Regents · · FY2010 · O/D
Sirtuins and nuclear receptors in aging and age-associated diseases
$2,165,707Xiaoling Li · National Institute Of Environmental Health Sciences · ZIA · FY2015 · ES
Measuring, Modeling and Controlling Heterogeneity
$2,164,435Joe W. Gray · Oregon Health & Science University · U54 · FY2019 · CA
Alzheimer's disease drug development
$2,163,807Nigel H. Greig · National Institute On Aging · ZIA · FY2019 · AG
NONINVASIVE NEUROMODULATION TO SLOW ALS USING NEURONAL HYPEREXCITABILITY SUPPRESSION
$2,163,115Pathmaker Neurosystems Inc. · · FY2025 · Defense Health Agency
The Psychophysiology Of Fear And Anxiety
$2,162,173Christian Grillon · National Institute Of Mental Health · ZIA · FY2010 · MH
IGF::OT::IGF
$2,160,247James Shikany · University Of Alabama At Birmingham · N01 · FY2014 · HL
The pathogenic relationship between neuronal activity and C9orf72-linked neurodegeneration
$2,159,840Aaron Raymond Haeusler · Thomas Jefferson University · RF1 · FY2020 · NS
The Psychophysiology of Fear and Anxiety
$2,158,099Christian Grillon · National Institute Of Mental Health · ZIA · FY2016 · MH
Collaboration to Improve Blood Pressure in the US Black Belt- Addressing the Triple Threat
$2,157,452Andrea L Cherrington · University Of Alabama At Birmingham · UH3 · FY2017 · HL
Drug Repurposing Screening for Rare and Neglected Diseases
$2,156,297Wei Zheng · National Center For Advancing Translational Sciences · ZIA · FY2021 · TR
Characterization of neuronal ensembles activated during drug-induced behavior
$2,156,045Bruce Hope · National Institute On Drug Abuse · ZIA · FY2017 · DA
DEVELOPMENT OF COPPER ATSM AS A THERAPEUTIC FOR SOD-FAMILIAL AND SPORADIC ALS
$2,155,843Oregon State University · · FY2015 · Department of Defense